Wealth Alliance Dexcom Inc Transaction History

Wealth Alliance

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$86.06 - $137.93 $74,872 - $119,999	-870 Reduced 16.05%	4,550 $424,000
Q2 2023 Aug 02, 2023	SELL	$112.47 - $130.98 $3,711 - $4,322	-33 Reduced 0.61%	5,420 $696,000
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $4,680 - $5,531	-45 Reduced 0.82%	5,453 $633,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $126,960 - $183,268	1,494 Added 37.31%	5,498 $622,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $21,988 - $27,123	288 Added 7.75%	4,004 $322,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $194,927 - $380,995	2,867 Added 337.69%	3,716 $277,000
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $15,711 - $21,743	167 Added 24.49%	849 $434,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $7,792 - $9,769	60 Added 9.65%	682 $366,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $9,817 - $13,172	92 Added 17.36%	622 $341,000
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $42,924 - $57,202	530 New	530 $226,000

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.